MedAdvisor Limited
ASX:MDR.AX
0.25 (AUD) • At close November 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 122.106 | 97.963 | 67.75 | 38.773 | 9.603 | 8.242 | 6.605 | 4.243 | 1.426 | 1.646 | 1.065 | 0.857 | 0 | 0 |
| Cost of Revenue
| 47.857 | 85.377 | 69.592 | 44.83 | 13.235 | 10.027 | 6.056 | 3.84 | 2.92 | 1.79 | 1.428 | 1.026 | 0 | 0 |
| Gross Profit
| 74.249 | 12.586 | -1.842 | -6.057 | -3.632 | -1.785 | 0.549 | 0.403 | -1.494 | -0.144 | -0.363 | -0.168 | 0 | 0 |
| Gross Profit Ratio
| 0.608 | 0.128 | -0.027 | -0.156 | -0.378 | -0.217 | 0.083 | 0.095 | -1.048 | -0.088 | -0.341 | -0.196 | 0 | 0 |
| Reseach & Development Expenses
| 0 | 7.507 | 6.151 | 4.81 | 2.504 | 7.38 | 3.662 | 1.81 | 0.231 | 0.15 | 0.821 | 1.026 | 0 | 0 |
| General & Administrative Expenses
| 46.422 | 41.47 | 32.237 | 0.282 | 0.218 | 0.187 | 0.181 | 0.194 | 0.148 | 0.121 | 1.316 | 1.855 | 0.32 | 0.035 |
| Selling & Marketing Expenses
| 2.678 | 3.263 | 2.657 | 2.244 | 5.661 | 5.204 | 4.126 | 2.89 | 0.864 | 0.397 | 0.386 | 0.077 | 0 | 0 |
| SG&A
| 49.1 | 12.796 | 8.196 | 7.445 | 4.996 | 5.391 | 4.308 | 3.084 | 1.012 | 0.121 | 1.316 | 1.855 | 0.32 | 0.035 |
| Other Expenses
| 22.451 | 0 | 0 | 1.469 | 1.359 | 0.817 | 0.634 | 0.563 | 0.281 | 0.547 | 0.005 | -0.192 | 0.793 | 0.06 |
| Operating Expenses
| 71.552 | 20.303 | 14.347 | 12.256 | 7.501 | 6.451 | 5.158 | 3.928 | 1.627 | 0.668 | 11.162 | 3.648 | 1.113 | 0.095 |
| Operating Income
| 2.697 | -7.717 | -16.188 | -18.313 | -11.133 | -8.22 | -4.597 | -3.453 | -2.916 | -0.668 | -11.162 | -3.648 | -1.113 | -0.095 |
| Operating Income Ratio
| 0.022 | -0.079 | -0.239 | -0.472 | -1.159 | -0.997 | -0.696 | -0.814 | -2.045 | -0.406 | -10.478 | -4.256 | 0 | 0 |
| Total Other Income Expenses Net
| -1.773 | -2.798 | -1.54 | -0.246 | 0.165 | 0.118 | 0.143 | 0.023 | -0.155 | 0.001 | 0.005 | -0.192 | 0.12 | 0.024 |
| Income Before Tax
| 0.924 | -10.515 | -17.728 | -18.559 | -10.968 | -8.101 | -4.454 | -3.43 | -3.071 | -0.667 | -11.144 | -3.747 | -0.993 | -0.07 |
| Income Before Tax Ratio
| 0.008 | -0.107 | -0.262 | -0.479 | -1.142 | -0.983 | -0.674 | -0.808 | -2.154 | -0.405 | -10.461 | -4.372 | 0 | 0 |
| Income Tax Expense
| 0.131 | 0.79 | -0.24 | -4.187 | -1.188 | -0.75 | -0.634 | -0.522 | -0.281 | 0.003 | 0.021 | -0.093 | 0 | 0 |
| Net Income
| 0.792 | -11.305 | -17.346 | -13.949 | -9.585 | -8.101 | -4.454 | -3.43 | -3.071 | -0.667 | -11.144 | -3.747 | -0.993 | -0.07 |
| Net Income Ratio
| 0.006 | -0.115 | -0.256 | -0.36 | -0.998 | -0.983 | -0.674 | -0.808 | -2.154 | -0.405 | -10.461 | -4.372 | 0 | 0 |
| EPS
| 0.001 | -0.021 | -0.046 | -0.044 | -0.041 | -0.042 | -0.026 | -0.028 | -0.039 | -0.056 | -1.05 | -0.47 | -0.27 | -0.066 |
| EPS Diluted
| 0.001 | -0.021 | -0.046 | -0.044 | -0.041 | -0.042 | -0.026 | -0.028 | -0.038 | -0.056 | -1.05 | -0.47 | -0.27 | -0.066 |
| EBITDA
| 7.048 | -2.364 | -11.289 | -15.101 | -10.62 | -8.109 | -4.571 | -3.405 | -2.882 | -0.663 | -11.123 | -3.646 | -1.113 | -0.095 |
| EBITDA Ratio
| 0.058 | -0.024 | -0.167 | -0.389 | -1.106 | -0.984 | -0.692 | -0.802 | -2.021 | -0.403 | -10.442 | -4.254 | 0 | 0 |